On December 20, 2017 BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, reported that Adi Mohanty, Co-Chief Executive Officer, and Russell Skibsted, Chief Financial Officer, will host institutional investor and partnering meetings, at the LifeSci Advisors Corporate Access Event taking place in San Francisco, January 8-10, 2018 (Press release, BioTime, DEC 20, 2017, View Source;p=RssLanding&cat=news&id=2323507 [SID1234522723]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

One-on-one meetings with Mr. Mohanty and/or Mr. Skibsted may be arranged by registering through LifeSci Advisors, LLC, by making a request via e-mail at [email protected], or by contacting David Nakasone, Director of Investor Relations at BioTime, at 510-871-4188 or [email protected].